Cognitive reserve involves decision making and is associated with left parietal and hippocampal hypertrophy in neurodegeneration.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 27 11 2023
accepted: 05 06 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

Cognitive reserve is the ability to actively cope with brain deterioration and delay cognitive decline in neurodegenerative diseases. It operates by optimizing performance through differential recruitment of brain networks or alternative cognitive strategies. We investigated cognitive reserve using Huntington's disease (HD) as a genetic model of neurodegeneration to compare premanifest HD, manifest HD, and controls. Contrary to manifest HD, premanifest HD behave as controls despite neurodegeneration. By decomposing the cognitive processes underlying decision making, drift diffusion models revealed a response profile that differs progressively from controls to premanifest and manifest HD. Here, we show that cognitive reserve in premanifest HD is supported by an increased rate of evidence accumulation compensating for the abnormal increase in the amount of evidence needed to make a decision. This higher rate is associated with left superior parietal and hippocampal hypertrophy, and exhibits a bell shape over the course of disease progression, characteristic of compensation.

Identifiants

pubmed: 38890487
doi: 10.1038/s42003-024-06416-x
pii: 10.1038/s42003-024-06416-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

741

Subventions

Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-17-EURE-0017
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-11-JSH2-006-1

Informations de copyright

© 2024. The Author(s).

Références

Tabrizi, S. J. et al. Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet. Neurol. 8, 791–801 (2009).
pubmed: 19646924 pmcid: 3725974 doi: 10.1016/S1474-4422(09)70170-X
Papoutsi, M., Labuschagne, I., Tabrizi, S. J. & Stout, J. C. The cognitive burden in Huntington’s disease: pathology, phenotype, and mechanisms of compensation. Mov. Disord. 29, 673–683 (2014).
pubmed: 24757115 doi: 10.1002/mds.25864
Soloveva, M. V., Jamadar, S. D., Poudel, G. & Georgiou-Karistianis, N. A critical review of brain and cognitive reserve in Huntington’s disease. Neurosci. Biobehav Rev. 88, 155–169 (2018).
pubmed: 29535068 doi: 10.1016/j.neubiorev.2018.03.003
Gregory, S. et al. Testing a longitudinal compensation model in premanifest Huntington’s disease. Brain 141, 2156–2166 (2018).
pubmed: 29788038 pmcid: 6022638 doi: 10.1093/brain/awy122
Stern, Y., Barnes, C. A., Grady, C., Jones, R. N. & Raz, N. Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience. Neurobiol. Aging 83, 124–129 (2019).
pubmed: 31732015 pmcid: 6859943 doi: 10.1016/j.neurobiolaging.2019.03.022
Barulli, D. & Stern, Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn. Sci. 17, 502–509 (2013).
pubmed: 24018144 doi: 10.1016/j.tics.2013.08.012
Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12 month longitudinal analysis. Lancet Neurol. 10, 31–42 (2011).
pubmed: 21130037 doi: 10.1016/S1474-4422(10)70276-3
Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S. & Hayden, M. R. A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clin. Genet. 65, 267–277 (2004).
pubmed: 15025718 doi: 10.1111/j.1399-0004.2004.00241.x
Ross, C. A. et al. Movement disorder society task force viewpoint: Huntington’s disease diagnostic categories. Mov. Disord. Clin. Pr. 6, 541–546 (2019).
doi: 10.1002/mdc3.12808
Malejko, K. et al. Prodromal Huntington disease as a model for functional compensation of early neurodegeneration. PLoS One 9, 1–14 (2014).
doi: 10.1371/journal.pone.0114569
Zhang, J. et al. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease. Brain 139, 161–173 (2016).
pubmed: 26582559 doi: 10.1093/brain/awv331
Anders, R., Riès, S., Van Maanen, L. & Alario, F. X. Lesions to the left lateral prefrontal cortex impair decision threshold adjustment for lexical selection. Cogn. Neuropsychol. 34, 1–20 (2017).
pubmed: 28632042 pmcid: 8191230 doi: 10.1080/02643294.2017.1282447
Wiecki, T. V. et al. A computational cognitive biomarker for early-stage Huntington’s disease. PLoS One 11, e0148409 (2016).
pubmed: 26872129 pmcid: 4752511 doi: 10.1371/journal.pone.0148409
Le Stanc, L. et al. Language disorders in patients with striatal lesions: deciphering the role of the striatum in language performance. Cortex 166, 91–106 (2023).
pubmed: 37354871 doi: 10.1016/j.cortex.2023.04.016
Hinzen, W. et al. A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington’s disease. Cortex 100, 71–83 (2018).
pubmed: 28859906 pmcid: 5845634 doi: 10.1016/j.cortex.2017.07.022
de Diego Balaguer, R. et al. Striatal degeneration impairs language learning: evidence from Huntington ’s disease. Brain 131, 2870–2881 (2008).
pubmed: 18842608 doi: 10.1093/brain/awn242
Németh, D. et al. Language deficits in pre-symptomatic Huntington’s disease: evidence from Hungarian. Brain Lang. 121, 248–253 (2012).
pubmed: 22538085 pmcid: 3350800 doi: 10.1016/j.bandl.2012.04.001
Jacquemot, C. & Bachoud-Lévi, A. C. Striatum and language processing: where do we stand? Cognition 213, 104785 (2021).
pubmed: 34059317 doi: 10.1016/j.cognition.2021.104785
Giavazzi, M. et al. The role of the striatum in linguistic selection: evidence from Huntington’s disease and computational modeling. Cortex 109, 189–204 (2018).
pubmed: 30388440 doi: 10.1016/j.cortex.2018.08.031
Ratcliff, R. & Mckoon, G. The diffusion decision model: theory and data for two-choice decision tasks. Neural. Comput. 20, 873–922 (2008).
pubmed: 18085991 pmcid: 2474742 doi: 10.1162/neco.2008.12-06-420
Mulder, M. J., van Maanen, L. & Forstmann, B. U. Perceptual decision neurosciences—a model-based review. Neuroscience 277, 872–884 (2014).
pubmed: 25080159 doi: 10.1016/j.neuroscience.2014.07.031
Huntington Study Group Unified Huntington’s disease rating scale: reliability and consistency. Mov. Disord. 11, 136–142 (1996).
doi: 10.1002/mds.870110204
Tombaugh, T. N. Trail making test A and B: normative data stratified by age and education. Arch. Clin. Neuropsychol. 19, 203–214 (2004).
pubmed: 15010086 doi: 10.1016/S0887-6177(03)00039-8
Ratcliff, R. A theory of memory retrieval. Psychol. Rev. 85, 59–108 (1978).
doi: 10.1037/0033-295X.85.2.59
Oosterloo, M. et al. Disease onset in Huntington’s disease: when is the conversion? Mov. Disord. Clin. Pr. 8, 352–360 (2021).
doi: 10.1002/mdc3.13148
Tabrizi, S. J. et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36 month observational data. Lancet Neurol. 12, 637–649 (2013).
pubmed: 23664844 doi: 10.1016/S1474-4422(13)70088-7
Biglan, K. M. et al. Motor abnormalities in premanifest persons with Huntington’s disease: the PREDICT-HD study. Mov. Disord. 24, 1763–1772 (2009).
pubmed: 19562761 pmcid: 3048804 doi: 10.1002/mds.22601
Ratcliff, R. & Tuerlinckx, F. Estimating parameters of the diffusion model: approaches to dealing with contaminant reaction times and parameter variability. Psychon. Bull. Rev. 9, 438–481 (2002).
pubmed: 12412886 pmcid: 2474747 doi: 10.3758/BF03196302
Snowden, J. S., Craufurd, D., Thompson, J. & Neary, D. Psychomotor, executive, and memory function in preclinical Huntington’s disease. J. Clin. Exp. Neuropsychol. 24, 133–145 (2002).
pubmed: 11992196 doi: 10.1076/jcen.24.2.133.998
Stout, J. C. et al. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. J. Neurol. Neurosurg. Psychiatry 83, 687–694 (2012).
pubmed: 22566599 doi: 10.1136/jnnp-2011-301940
Feigin, A. et al. Preclinical Huntington’s disease: compensatory brain responses during learning. Ann. Neurol. 59, 53–59 (2006).
pubmed: 16261565 pmcid: 2519955 doi: 10.1002/ana.20684
Klöppel, S. et al. Functional compensation of motor function in pre-symptomatic Huntingtons disease. Brain 132, 1624–1632 (2009).
pubmed: 19369489 pmcid: 2685920 doi: 10.1093/brain/awp081
Wolf, R. C. et al. Brain activation and functional connectivity in premanifest Huntington’s disease during states of intrinsic and phasic alertness. Hum. Brain Mapp. 33, 2161–2173 (2012).
pubmed: 22887827 doi: 10.1002/hbm.21348
Pini, L. et al. Striatal connectivity in pre-manifest Huntington’s disease is differentially affected by disease burden. Eur. J. Neurol. 27, 2147–2157 (2020).
pubmed: 32602565 doi: 10.1111/ene.14423
Pini, L. et al. Aberrant brain network connectivity in presymptomatic and manifest Huntington’s disease: a systematic review. Hum. Brain Mapp. 41, 256–269 (2020).
pubmed: 31532053 doi: 10.1002/hbm.24790
Fan, J., McCandliss, B. D., Fossella, J., Flombaum, J. I. & Posner, M. I. The activation of attentional networks. Neuroimage 26, 471–479 (2005).
pubmed: 15907304 doi: 10.1016/j.neuroimage.2005.02.004
Kristensen, L. B., Wang, L., Petersson, K. M. & Hagoort, P. The interface between language and attention: prosodic focus marking recruits a general attention network in spoken language comprehension. Cereb. Cortex 23, 1836–1848 (2013).
pubmed: 22763170 doi: 10.1093/cercor/bhs164
Mitko A. et al. Individual differences in sustained attention are associated with cortical thickness. Hum. Brain Mapp. 40, 3243-3253 (2019).
Forstmann, B. U. et al. Cortico-striatal connections predict control over speed and accuracy in perceptual decision making. Proc. Natl Acad. Sci. USA 107, 15916–15920 (2010).
pubmed: 20733082 pmcid: 2936628 doi: 10.1073/pnas.1004932107
André, V. M., Cepeda, C. & Levine, M. S. Dopamine and glutamate in Huntington’s disease: a balancing act. CNS Neurosci. Ther. 16, 163–178 (2010).
pubmed: 20406248 pmcid: 3118459 doi: 10.1111/j.1755-5949.2010.00134.x
Marrakchi-Kacem, L. et al. Mapping cortico-striatal connectivity onto the cortical surface: a new tractography-based approach to study Huntington disease. PLoS One 8, e53135 (2013).
pubmed: 23405066 pmcid: 3566172 doi: 10.1371/journal.pone.0053135
Poudel, G. R. et al. White matter connectivity reflects clinical and cognitive status in Huntington’s disease. Neurobiol. Dis. 65, 180–187 (2014).
pubmed: 24480090 doi: 10.1016/j.nbd.2014.01.013
Cavanagh, J. F. et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat. Neurosci. 14, 1462–1467 (2011).
pubmed: 21946325 pmcid: 3394226 doi: 10.1038/nn.2925
Simons, M., Levin, J. & Dichgans, M. Tipping points in neurodegeneration. Neuron 111, 2954–2968 (2023).
pubmed: 37385247 doi: 10.1016/j.neuron.2023.05.031
Hart, E. P. et al. Longitudinal pilot-study of sustained attention to response task and P300 in manifest and pre-manifest Huntington’s disease. J. Neuropsychol. 9, 10–20 (2015).
pubmed: 24151858 doi: 10.1111/jnp.12031
Ziegler, S., Pedersen, M. L., Mowinckel, A. M. & Biele, G. Modelling ADHD: a review of ADHD theories through their predictions for computational models of decision-making and reinforcement learning. Neurosci. Biobehav. Rev. 71, 633–656 (2016).
pubmed: 27608958 doi: 10.1016/j.neubiorev.2016.09.002
Nunez, M. D., Srinivasan, R. & Vandekerckhove, J. Individual differences in attention influence perceptual decision making. Front. Psychol. 8, 1–13 (2015).
Yonelinas, A. P. The hippocampus supports high-resolution binding in the service of perception, working memory and long-term memory. Behav. Brain Res. 254, 34–44 (2013).
pubmed: 23721964 pmcid: 3773061 doi: 10.1016/j.bbr.2013.05.030
Córdova N. I., Browne N. B. T., Aly M. Focusing on what matters: modulation of the human hippocampus by relational attention. Hippocampus 29, 1025–1037 (2019).
Soto, D., Hodsoll, J., Rotshtein, P. & Humphreys, G. W. Automatic guidance of attention from working memory. Trends Cogn. Sci. 12, 342–348 (2008).
pubmed: 18693131 doi: 10.1016/j.tics.2008.05.007
Corbetta, M., Patel, G. & Shulman, G. L. The reorienting system of the human brain: from environment to theory of mind. Neuron 58, 306–324 (2008).
pubmed: 18466742 pmcid: 2441869 doi: 10.1016/j.neuron.2008.04.017
Hart, E. P. et al. Deficient sustained attention to response task and P300 characteristics in early Huntington’s disease. J. Neurol. 259, 1191–1198 (2012).
pubmed: 22143614 doi: 10.1007/s00415-011-6334-0
Jacquemot C., Pallier C., LeBihan D., Dehaene S., Dupoux E. Phonological grammar shapes the auditory cortex: a functional magnetic resonance imaging study. J. Neurosci. 23, 9541–9546 (2003).
Macdonald, V., Halliday, G. M., Trent, R. J. & McCusker, E. A. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington’s disease. Neuropathol. Appl. Neurobiol. 23, 492–495 (1997).
pubmed: 9460715 doi: 10.1111/j.1365-2990.1997.tb01326.x
Fortea, J. et al. Increased cortical thickness and caudate volume precede atrophy in psen1 mutation carriers. J. Alzheimer’s Dis. 22, 909–922 (2010).
doi: 10.3233/JAD-2010-100678
Nopoulos, P. C. et al. Cerebral cortex structure in prodromal Huntington disease. Neurobiol. Dis. 40, 544–554 (2010).
pubmed: 20688164 pmcid: 2955824 doi: 10.1016/j.nbd.2010.07.014
Luders, E., Toga, A. W., Lepore, N. & Gaser, C. The underlying anatomical correlates of long-term meditation: larger hippocampal and frontal volumes of gray matter. Neuroimage 45, 672–678 (2009).
pubmed: 19280691 doi: 10.1016/j.neuroimage.2008.12.061
Suh, J. S. et al. Cortical thickness in major depressive disorder: a systematic review and meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 88, 287–302 (2019).
pubmed: 30118825 doi: 10.1016/j.pnpbp.2018.08.008
Paulsen, J. S. et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington’s disease. Am. J. Neuroradiol. 25, 1715–1721 (2004).
pubmed: 15569736 pmcid: 8148746
Klöppel, S. et al. Compensation in preclinical Huntington’s disease: evidence from the Track-on HD study. EBioMedicine 2, 1420–1429 (2015).
pubmed: 26629536 pmcid: 4634199 doi: 10.1016/j.ebiom.2015.08.002
Teichmann, M., Darcy, I., Bachoud-Lévi, A.-C. & Dupoux, E. The role of the striatum in phonological processing. evidence from early stages of Huntington’s disease. Cortex 45, 839–849 (2009).
pubmed: 19249020 doi: 10.1016/j.cortex.2008.12.005
Dehaene-Lambertz, G. & Baillet, S. A phonological representation in the infant brain. Neuroreport 9, 1885–1888 (1998).
pubmed: 9665620 doi: 10.1097/00001756-199806010-00040
Näätänen, R. et al. Language-specific phoneme representations revealed by electric and magnetic brain responses. Nature 385, 432–434 (1997).
pubmed: 9009189 doi: 10.1038/385432a0
Dehaene-Lambertz, G., Dupoux, E. & Gout, A. Electrophysiological correlates of phonological processing: a cross-linguistic study. J. Cogn. Neurosci. 12, 635–647 (2000).
pubmed: 10936916 doi: 10.1162/089892900562390
Sun, Y. et al. Complex linguistic rules modulate early auditory brain responses. Brain Lang. 149, 55–65 (2015).
pubmed: 26186230 doi: 10.1016/j.bandl.2015.06.009
Cohen, J., MacWhinney, B., Flatt, M., Provost, J. & PsyScope:, A. new graphic interactive environment for designing psychology experiments. Behav. Res. Methods Instrum. Comput. 25, 257–271 (1993).
doi: 10.3758/BF03204507
Wiecki, T. V., Sofer, I. & Michael, F. J. HDDM: Hierarchical Bayesian estimation of the drift-diffusion model in Python. Front. Neuroin. 7, 1–10 (2013).
doi: 10.3389/fninf.2013.00014
Ratcliff, R. & Childers, R. Individual differences and fitting methods for the two-choice diffusion model of decision making. Decision 2, 237–279 (2015).
doi: 10.1037/dec0000030
Gelman, A. & Rubin, D. B. Inference from iterative simulation using multiple sequences. Stat. Sci. 7, 457–511 (1992).
doi: 10.1214/ss/1177011136
Spiegelhalter, D. J., Best, N. G., Carlin, B. P. & van der Linde, A. Bayesian measures of model complexity and fit. J. R. Stat. Soc. Ser. B 64, 583–639 (2002).
doi: 10.1111/1467-9868.00353
Pereira J. B. et al. Assessment of cortical degeneration in patients with Parkinson’s disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum. Brain Mapp. 33, 2521–2534 (2011).
Lemaitre, H. et al. Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? Neurobiol. Aging 33, 617.e1–617.e9 (2012).
pubmed: 20739099 doi: 10.1016/j.neurobiolaging.2010.07.013
Hutton, C., Draganski, B., Ashburner, J. & Weiskopf, N. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage 48, 371–380 (2009).
pubmed: 19559801 doi: 10.1016/j.neuroimage.2009.06.043
Fischl B. et al. Neurotechnique whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355 (2002).
Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl Acad. Sci. USA 97, 11050–11055 (2000).
pubmed: 10984517 pmcid: 27146 doi: 10.1073/pnas.200033797
Fischl B., Sereno M. & Dale A. Cortical surface-based analysis: I. Segmentation and surface reconstruction. NeuroImage. 9, 179–194 (1999).
Wickham, H. et al. Welcome to the tidyverse. J. Open Source Softw. 4, 1686 (2019).
doi: 10.21105/joss.01686
Posit Team. RStudio: Integrated Development Environment for R. http://www.posit.co/ (2023).

Auteurs

Lorna Le Stanc (L)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.
Université Paris Cité, LaPsyDÉ, CNRS, F-75005 Paris, France.

Marine Lunven (M)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.

Maria Giavazzi (M)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.

Agnès Sliwinski (A)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.
AP-HP, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, Créteil, France.

Katia Youssov (K)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.
AP-HP, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, Créteil, France.

Anne-Catherine Bachoud-Lévi (AC)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France.
AP-HP, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, Créteil, France.

Charlotte Jacquemot (C)

Département d'Études Cognitives, École Normale Supérieure-PSL, Paris, France. charlotte.jacquemot@ens.psl.eu.
Institut Mondor de Recherche Biomédicale, Inserm U955, Equipe E01 Neuropsychologie Interventionnelle, Créteil, France. charlotte.jacquemot@ens.psl.eu.
Université Paris-Est Créteil, Faculté de Santé, Créteil, France. charlotte.jacquemot@ens.psl.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH